Nicholas Mathews, Co-Founder of The Brain Lab: CEOs Flock to PrTMS to Maintain Peak Job Performance

The Brain Lab’s groundbreaking technologies optimize neural function to treat mental illness and help high performers attain their full potential. In addition to providing NAD therapies, IV drips, and neurofeedback, The Brain Lab’s clinics offer Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS), a brand-new noninvasive therapy.

PrTMS is a drug-free, non-invasive therapy that has been evolving and advancing for decades. On this episode of the Grit Daily Startup, Nicholas explains how TMS treatment uses magnetic pulses to stimulate electrical activity in the brain’s neurons. Non-personalized versions of this therapy have been cleared by the FDA for use in treating a limited number of conditions, including Major Depressive Disorder, Obsessive-Compulsive Disorder, and pain associated with certain migraine headaches.

Personalized repetitive Transcranial Magnetic Stimulation (PrTMS) is TMS – but with a smarter, more sophisticated approach. Unlike conventional TMS that is one-size-fits-all, PrTMS utilizes a proprietary, patent-pending protocol to develop personalized treatment plans that customize the TMS therapy delivered to each patient – which may help patients achieve optimal results. PrTMS may be successful in treating a variety of brain health conditions.